PGDx Raises $2.8M in Private Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer genome analysis firm Personal Genome Diagnostics today announced it raised $2.8 million in private funding in its first external financing round.

Undisclosed investors participated in the financing, which will be used to support further development and marketing of the company's circulating tumor DNA assays.

The company today also launched its METDetect Assay for detecting MET gene amplifications in the circulation of cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.